SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001654954-20-005610
Filing Date
2020-05-15
Accepted
2020-05-15 15:19:21
Documents
1
Period of Report
2020-03-31
Effectiveness Date
2020-05-15

Document Format Files

Seq Description Document Type Size
1 NT 10-Q sbfm_nt10q.htm NT 10-Q 38612
  Complete submission text file 0001654954-20-005610.txt   39942
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 20884410
SIC: 8731 Services-Commercial Physical & Biological Research